Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Gunderson

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Oncotargets and Therapy|August 10, 2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancerL E Dockery, C C Gunderson, K N Moore
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 4, 2008
Clostridium difficile colitis in lung transplantationC C Gunderson, M R Gupta, F Lopez, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Oncotargets and Therapy|August 10, 2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancerL E Dockery, C C Gunderson, K N Moore
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 4, 2008
Clostridium difficile colitis in lung transplantationC C Gunderson, M R Gupta, F Lopez, et al.
Pageof 1